UNSPSC 51161558: Nivimedone

This classification denotes a mast cell stabilizer with the molecular formula C11H9NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 1M887244YI chemically known as 1h-indene-1,3(2h)-dione, 5,6-dimethyl-2-nitro-, ion(1-) but generally known as nivimedone, which bears US NIH Compound Identifier 64753. European Medicines Agency schedules Nivimedone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09333MIG.

UNSPSC 51161558 Nivimedone is a Commodity code capturing pharmaceutical products procured through cooperative purchasing vehicles for multi-state distribution to state and local government healthcare facilities. State and local buyers under this code source generic pharmaceuticals and over-the-counter products through established wholesale distribution channels, requiring vendors to meet federal manufacturing compliance standards, maintain broad insurance coverage, and provide flexible pricing models tied to authorized wholesaler networks. The primary issuing bodies are multi-state cooperative purchasing alliances and state health and human services departments that aggregate demand across participating jurisdictions to achieve volume pricing and simplified procurement administration.

The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across Minnesota, Oregon, and other participating jurisdictions. MMCAP requires vendors to supply products through three authorized wholesalers—AmerisourceBergen Drug Corporation (Cencora), Cardinal Health 110 and 112, and Morris & Dickson Co., LLC—with awarded contracts effective July 1, 2026. Evaluation is weighted heavily on price competitiveness (75 percent), with the balance distributed across fixed pricing (10 percent), EDI capability (5 percent), administrative fee compliance (5 percent), and data format requirements (5 percent). Vendors must certify cGMP and DSCSA compliance, maintain relationships with at least two authorized wholesalers with chargeback capability, and carry workers' compensation, commercial general liability ($5,000,000 per occurrence), network security and privacy liability ($2,000,000), and professional liability ($2,000,000). The contract runs two years for new responders with optional MMCAP extensions, or aligns with existing agreement terms through June 30, 2028 for incumbents.